Clinical trial · Interventional
Lateral Neck Lymph Node Mapping in Thyroid Cancer
Lateral Neck Lymph Node Mapping in Papillary Thyroid Carcinoma
NCT04312087CI-TRIAL-00044121unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study includes papillary thyroid cancer patients who have unpalpable lateral neck lymph nodes but suspicious on ultrasound and/or CT. Carbon nanoparticles is used as the tracer for lateral neck lymph node mapping.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Thyroid Cancer | Malignant Thyroid Gland Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Lateral neck sentinel lymph node biopsy | Procedure | — | UNRESOLVED |
| Modified lateral neck lymph node dissection | Procedure | — | UNRESOLVED |
| Super selective lateral neck lymph node dissection | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- MLND
- description
- Modified lateral neck dissection (compartment II-V) is performed in all patients.
- interventionNames
- Procedure: Modified lateral neck lymph node dissection
- type
- EXPERIMENTAL
- label
- SLNB
- description
- Sentinel lymph node biopsy in the lateral neck is performed. The decision of neck dissection is based on the result of sentinel lymph node biopsy.
- interventionNames
- Procedure: Lateral neck sentinel lymph node biopsy
- Procedure: Modified lateral neck lymph node dissection
- Procedure: Super selective lateral neck lymph node dissection
Primary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 14 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Newly diagnosed papillary thyroid cancer * The maximum diameter of the thyroid cancer \<3 cm with enough normal thyroid tissue for tracer injection * Unpalpable lateral neck lymph nodes * Ultrasound and CT showed suspected lateral neck lymph nodes \<2 cm Exclusion Criteria: * Previously treated thyroid cancer * High risk thyroid cancer (e.g. with severe extra-adenial invasion or extensive lymph node metastasis or poorly differentiated thyroid cancer) * Patients with distant metastasis
References
Publications (0)
Data not yet available
No reference posted for this study.